Irinotecan-induced mucositis is associated with changes in intestinal mucins
about
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsChemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.Ocoxin oral solution® as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liverPro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositisIrinotecan-Induced Gastrointestinal Dysfunction Is Associated with Enteric Neuropathy, but Increased Numbers of Cholinergic Myenteric Neurons.IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprintingMulti-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head anBovine Colostrum Modulates Myeloablative Chemotherapy-Induced Gut Toxicity in Piglets.Low-dose irradiation affects the functional behavior of oral microbiota in the context of mucositis.Amelioration of diabesity-induced colorectal ontogenesis by omega-3 fatty acids in mice.Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis.Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study.Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors.Interaction between host cells and microbes in chemotherapy-induced mucositis.New pharmacotherapy options for chemotherapy-induced alimentary mucositis.Microbiota and their role in the pathogenesis of oral mucositis.The role of oral flora in the development of chemotherapy-induced oral mucositis.Oral Nucleotides Only Minimally Improve 5-Fluorouracil-Induced Mucositis in Rats.Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis.Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis.Alterations in the small intestinal wall and motor function after repeated cisplatin in rat.Oxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon.
P2860
Q28079705-1B6D81D6-FD79-4B05-AD26-CE7E5BD9F7C0Q30318822-74868F89-8699-4C53-9DF7-DDB97B9CAF38Q33751204-6118EBCC-2EB1-4A69-9B9E-03099613E207Q33753588-55E832E6-3C0B-47C8-A5A0-BC335B4A1CF6Q33774788-22B37967-9ABD-4694-A270-C286A8A273CAQ33830896-B210C1BA-D752-4F2B-ADB7-73F37B2BE5A3Q34110225-45EB258D-5584-4073-A6DC-E6610C8D33ECQ34180799-2EF56C48-5241-4B5E-8769-4D50016D1259Q35644295-5577CBBC-35DA-485A-AFEE-00D10D3F5258Q35706909-187891C5-5BFD-4FF8-B480-8F9A330E42EAQ35958425-1AC8FE04-8B36-4F59-BF0A-3C4D2DD5DDB3Q36171894-0E91F5CD-B475-4836-91CE-43093B700E1FQ37071033-38494A24-B0BE-423D-8D4D-1C46F9D84DA5Q37303696-DC77C151-F4BD-4935-8EBC-847750B02AB8Q37441604-98DBFBF9-55C5-4F3C-92AD-6DDA9CC693EFQ37731433-DB8E29D5-2568-4FE9-B564-E3B8A7F621E0Q38088252-2C95EEDD-FE63-4900-9552-4EE0C2D4C5C7Q38102867-92EC4745-BB4F-4B85-86C7-D175580274C9Q38175515-05FF65D4-B12B-4D6A-80EA-97EF8AD2A2B6Q38181186-205CAA00-91BB-4660-BED9-A23306B4A88FQ38185099-C307F83F-109D-4F84-98D5-4998A6FE64BEQ38973185-F3AE53AA-1277-4E06-82A5-36CA623BA9C5Q42113023-219A801E-AAC1-43E7-9145-132CC42D6B4AQ48024495-5568D82F-4548-40C2-A94B-EFD8E00B2D28Q48162828-7C5D0065-DA02-495D-9BFE-022A88F2DD20Q55198257-F73E5734-7C0E-43C0-95E6-5B632BDBAE8D
P2860
Irinotecan-induced mucositis is associated with changes in intestinal mucins
description
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im Juni 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/06/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/06/01)
@nl
наукова стаття, опублікована в червні 2009
@uk
مقالة علمية (نشرت في يونيو 2009)
@ar
name
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@ast
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@en
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@nl
type
label
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@ast
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@en
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@nl
prefLabel
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@ast
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@en
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@nl
P2093
P2860
P50
P1476
Irinotecan-induced mucositis is associated with changes in intestinal mucins
@en
P2093
Ann S J Yeoh
Dorothy M K Keefe
Jessica Laurence
Richard M Logan
P2860
P2888
P304
P356
10.1007/S00280-008-0855-Y
P577
2008-11-08T00:00:00Z
P6179
1003851568